Related Experiment Video
Updated: Dec 14, 2025
08:12
Fully Endoscopic Mitral Valve Repair with Percutaneous Cannulation of Groin Vessels
Published on: May 26, 2023
2.0K
Minimally invasive triple valve surgery: A single center experience
Michael G Moront1, Michael Kuehne1, Roberta E Redfern2
1Department of Cardiothoracic Surgery, ProMedica Toledo Hospital, Toledo, Ohio.
Journal of Cardiac Surgery
|July 16, 2020
Summary
Minimally invasive triple valve surgery (TVS) using femoral cannulation demonstrates excellent short-term survival with no hospital deaths. This approach offers an acceptable risk profile for complex valve disease treatment.
Area of Science:
- Cardiac Surgery
- Minimally Invasive Procedures
- Valvular Heart Disease
Background:
- Minimally invasive surgery is a standard for valve disease.
- Triple valve surgery (TVS) is complex and challenging.
- Assessing outcomes of minimally invasive TVS is crucial.
Purpose of the Study:
- To evaluate the morbidity and mortality associated with minimally invasive triple valve surgery (TVS).
- To describe the outcomes of patients undergoing minimally invasive TVS at our institution.
Main Methods:
- Retrospective review of minimally invasive TVS procedures from 2012 to 2019.
- Analysis of baseline, perioperative characteristics, and postoperative outcomes.
- Inclusion of patients who underwent TVS with or without additional procedures.
Main Results:
- Eighteen patients underwent minimally invasive TVS.
- No in-hospital mortality; 0% 30-, 90-, and 365-day mortality.
- Common complications included rhythm disturbances (5 patients requiring pacemakers), with low rates of neurologic complications and acute kidney injury.
Conclusions:
- Minimally invasive TVS using femoral cannulation is associated with an acceptable risk of complications.
- Excellent short- and intermediate-term survival rates were observed.
- This technique provides a viable option for complex valve disease.
More Related Videos
Related Concept Videos
01:26Mitral Stenosis III: Medical Management
155
Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
155
01:25Mitral Regurgitation III: Medical Management
176
Mitral regurgitation (MR) is characterized by retrograde blood circulation from the left ventricle into the left atrium due to inadequate mitral valve closure. The severity of the condition, symptoms, and underlying cause determine treatment strategies.Monitoring and Pharmacological TreatmentPatients with mild to moderate MR typically do not need immediate intervention but regular monitoring to assess progression and guide treatment. Patients with mild MR should have an echocardiogram every 3-5...
176
01:22Mitral Stenosis I: Introduction
232
Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
232
01:22Mitral Valve Prolapse II: Assessment and Management
245
IntroductionA range of clinical features characterizes Mitral Valve Prolapse (MVP), but it is important to note that many individuals with MVP are asymptomatic and may remain so throughout their lives. For those who do exhibit symptoms, the following are the key clinical features:Palpitations: This is a common symptom where individuals feel an irregular or rapid heartbeat. Palpitations in MVP are often due to arrhythmias such as premature ventricular contractions or supraventricular...
245